FDA.reportPublic FDA data

Sdamlo 5 MG Powder for Oral Solution

RxCUI
2726067
RxNorm name
Sdamlo 5 MG Powder for Oral Solution
Display name
Sdamlo 5 MG Powder for Oral Solution
Full name
Sdamlo 5 MG Powder for Oral Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
886a7f97-60a4-4206-a6c7-5206069ed487Sdamlo 5 MG Powder for Oral Solution [PSN] · amlodipine 5 MG Powder for Oral Solution [Sdamlo] [SBD] · Sdamlo 5 MG Powder for Oral Solution [SY]34These highlights do not include all the information needed to use Sdamlo safely and effectively. See full prescribing information for Sdamlo. Sdamlo (amlodipine) for oral solution. Initial U.S. Approval: 199220251103